Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Essay
  • Published:

From IFN to TNF: a journey into realms of lore

Nature Immunology volume 10, pages 555–557 (2009)Cite this article

Jan Vilcek relates how his work helped to identify some of the pleiotropic actions of tumor necrosis factor and contributed to the development of infliximab, the first medically useful tumor necrosis factor antagonist.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Vilcek, J. My fifty years with interferon. J. Interferon Cytokine Res. 27, 535–542 (2007).

    Article  CAS  Google Scholar 

  2. Vilcek, J. An interferon-like substance released from tickborne encephalitis virus-infected chick embryo fibroblast cells. Nature 187, 73–74 (1960).

    Article  CAS  Google Scholar 

  3. Vilcek, J. Interferon research BC (before cloning). Curr. Top. Microbiol. Immunol. 316, 9–22 (2007).

    CAS  PubMed  Google Scholar 

  4. Stone-Wolff, D.S. et al. Interrelationships of human interferon-γ with lymphotoxin and monocyte cytotoxin. J. Exp. Med. 159, 828–843 (1984).

    Article  CAS  Google Scholar 

  5. Carswell, E.A. et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666–3670 (1975).

    Article  CAS  Google Scholar 

  6. Aggarwal, B.B. et al. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260, 2345–2354 (1985).

    CAS  PubMed  Google Scholar 

  7. Nedwin, G.E. et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13, 6361–6373 (1985).

    Article  CAS  Google Scholar 

  8. Beutler, B. et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552–554 (1985).

    Article  CAS  Google Scholar 

  9. Tsujimoto, M., Yip, Y.K. & Vilcek, J. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc. Natl. Acad. Sci. USA 82, 7626–7630 (1985).

    Article  CAS  Google Scholar 

  10. Vilcek, J. et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med. 163, 632–643 (1986).

    Article  CAS  Google Scholar 

  11. Lin, J.-X. & Vilcek, J. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J. Biol. Chem. 262, 11908–11911 (1987).

    CAS  PubMed  Google Scholar 

  12. Kohase, M., Henriksen-DeStefano, D., May, L.T., Vilcek, J. & Sehgal, P.B. Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45, 659–666 (1986).

    Article  CAS  Google Scholar 

  13. Reis, L.F.L., Lee, T.H. & Vilcek, J. Tumor necrosis factor acts synergistically with autocrine interferon-β and increases interferon-β mRNA levels in human fibroblasts. J. Biol. Chem. 264, 16351–16354 (1989).

    CAS  PubMed  Google Scholar 

  14. Lee, T.H., Lee, G.W., Ziff, E.B. & Vilcek, J. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell. Biol. 10, 1982–1988 (1990).

    Article  CAS  Google Scholar 

  15. Lee, T.H., Wisniewski, H.-G. & Vilcek, J. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol. 116, 545–557 (1992).

    Article  CAS  Google Scholar 

  16. Wisniewski, H.-G., Burgess, W.H., Oppenheim, J.D. & Vilcek, J. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-α-inhibitor. Biochemistry 33, 7423–7429 (1994).

    Article  CAS  Google Scholar 

  17. Lee, G.W., Lee, T.H. & Vilcek, J. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J. Immunol. 150, 1804–1812 (1993).

    CAS  PubMed  Google Scholar 

  18. Wisniewski, H.G. & Vilcek, J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev. 15, 129–146 (2004).

    Article  CAS  Google Scholar 

  19. Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337–366 (2005).

    Article  CAS  Google Scholar 

  20. Beutler, B., Milsark, I.W. & Cerami, A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869–871 (1985).

    Article  CAS  Google Scholar 

  21. Knight, D.M. et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol. Immunol. 30, 1443–1453 (1993).

    Article  CAS  Google Scholar 

  22. Siegel, S.A. et al. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine 7, 15–25 (1995).

    Article  CAS  Google Scholar 

  23. Elliott, M.J. et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 36, 1681–1690 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, New York University Langone Medical Center, New York, New York, USA

    Jan Vilcek

Authors
  1. Jan Vilcek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vilcek, J. From IFN to TNF: a journey into realms of lore. Nat Immunol 10, 555–557 (2009). https://doi.org/10.1038/ni0609-555

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni0609-555

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing